Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             177 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A case-control study of the HER2 Ile655Val polymorphism in relation to risk of invasive breast cancer Nelson, Stephanie E
2005
3 p. R357-R364
artikel
2 A case-only analysis of the interaction between N-acetyltransferase 2 haplotypes and tobacco smoke in breast cancer etiology Lash, Timothy L
2005
3 p. R385-R393
artikel
3 A constant risk for familial breast cancer? A population-based family study Czene, Kamila
2009
3 artikel
4 Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study Ritte, Rebecca
2012
3 artikel
5 Adolescent diet and risk of breast cancer Frazier, A Lindsay
2003
3 p. R59-R64
artikel
6 Allelic loss on chromosome band 18p11.3 occurs early and reveals heterogeneity in breast cancer progression Kittiniyom, Kanokwan
2001
3 p. 192-198
artikel
7 Amphiregulin mediates progesterone-induced mammary ductal development during puberty Aupperlee, Mark D
2013
3 artikel
8 Analysis of tumor environmental response and oncogenic pathway activation identifies distinct basal and luminal features in HER2-related breast tumor subtypes Gatza, Michael L
2011
3 artikel
9 An oestrogen-dependent model of breast cancer created by transformation of normal human mammary epithelial cells Duss, Stephan
2007
3 artikel
10 A novel cell culture model for studying differentiation and apoptosis in the mouse mammary gland Gordon, Katrina E
2000
3 p. 222-235
artikel
11 Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-α and survivin Vanderlaag, Kathryn E
2010
3 artikel
12 Antiproliferative and cytostatic effects of the natural product eupatorin on MDA-MB-468 human breast cancer cells due to CYP1-mediated metabolism Androutsopoulos, Vasilis
2008
3 artikel
13 A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients Habel, Laurel A
2006
3 artikel
14 A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer Serrano, Davide
2013
3 artikel
15 A screen for germline mutations in the gene encoding CCCTC-binding factor (CTCF) in familial non-BRCA1/BRCA2 breast cancer Zhou, Xiao-Lei
2004
3 p. R187-R190
artikel
16 Assessment of the proliferative, apoptotic and cellular renovation indices of the human mammary epithelium during the follicular and luteal phases of the menstrual cycle Navarrete, Maria Alicia H
2005
3 p. R306-R313
artikel
17 Association of TP53 codon 72 polymorphism and the outcome of adjuvant therapy in breast cancer patients Toyama, Tatsuya
2007
3 artikel
18 Autoantibodies as potential biomarkers for breast cancer Zhong, Li
2008
3 artikel
19 17beta-hydroxysteroid dehydrogenase type 1 modulates breast cancer protein profile and impacts cell migration Aka, Juliette A
2012
3 artikel
20 Biomarkers characterization of circulating tumour cells in breast cancer patients Nadal, Rosa
2012
3 artikel
21 Body fatness during childhood and adolescence and incidence of breast cancer in premenopausal women: a prospective cohort study Baer, Heather J
2005
3 p. R314-R325
artikel
22 Bone marrow-derived, alternatively activated macrophages enhance solid tumor growth and lung metastasis of mammary carcinoma cells in a Balb/C mouse orthotopic model Cho, Han Jin
2012
3 artikel
23 Breast cancer-specific mutations in CK1ε inhibit Wnt/β-catenin and activate the Wnt/Rac1/JNK and NFAT pathways to decrease cell adhesion and promote cell migration Foldynová-Trantírková, Silvie
2010
3 artikel
24 Breast cancer tumor growth estimated through mammography screening data Weedon-Fekjær, Harald
2008
3 artikel
25 Breast carcinoma and Lynch syndrome: molecular analysis of tumors arising in mutation carriers, non-carriers, and sporadic cases Lotsari, Johanna E
2012
3 artikel
26 Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study Patnaik, Jennifer L
2011
3 artikel
27 CD44 enhances invasion of basal-like breast cancer cells by upregulating serine protease and collagen-degrading enzymatic expression and activity Montgomery, Nicola
2012
3 artikel
28 Centromere protein-A, an essential centromere protein, is a prognostic marker for relapse in estrogen receptor-positive breast cancer McGovern, Susan L
2012
3 artikel
29 c-erbB2 and topoisomerase IIα protein expression independently predict poor survival in primary human breast cancer: a retrospective study Fritz, Peter
2005
3 p. R374-R384
artikel
30 Changes in magnetic resonance mammography due to hormone replacement therapy Pfleiderer, Stefan OR
2004
3 p. R232-R238
artikel
31 Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cells Cooney, Craig A
2011
3 artikel
32 Chromodomain helicase DNA binding protein 5 plays a tumor suppressor role in human breast cancer Wu, Xiao
2012
3 artikel
33 Circulating serum xenoestrogens and mammographic breast density Sprague, Brian L
2013
3 artikel
34 Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment Giuliano, Mario
2011
3 artikel
35 Clonogenic growth of human breast cancer cells co-cultured in direct contact with serum-activated fibroblasts Samoszuk, Michael
2005
3 p. R274-R283
artikel
36 Coffee consumption modifies risk of estrogen-receptor negative breast cancer Li, Jingmei
2011
3 artikel
37 Comprehensive splicing functional analysis of DNA variants of the BRCA2 gene by hybrid minigenes Acedo, Alberto
2012
3 artikel
38 Cooperative signaling between Wnt1 and integrin-linked kinase induces accelerated breast tumor development Oloumi, Arusha
2010
3 artikel
39 Correction: Functional magnetic resonance: biomarkers of response in breast cancer O'Flynn, Elizabeth AM
2011
3 artikel
40 Correlation of umbilical cord blood hormones and growth factors with stem cell potential: implications for the prenatal origin of breast cancer hypothesis Savarese, Todd M
2007
3 artikel
41 Crk adaptor proteins act as key signaling integrators for breast tumorigenesis Fathers, Kelly E
2012
3 artikel
42 C766T low-density lipoprotein receptor-related protein 1 (LRP1) gene polymorphism and susceptibility to breast cancer Beneš, Petr
2003
3 p. R77-R81
artikel
43 Cyclin D1 cooperates with p21 to regulate TGFβ-mediated breast cancer cell migration and tumor local invasion Dai, Meiou
2013
3 artikel
44 Cyclophosphamide- metabolizing enzyme polymorphisms and survival outcomes after adjuvant chemotherapy for node-positive breast cancer: a retrospective cohort study Gor, Priya P
2010
3 artikel
45 Cytokeratin-19 mRNA-positive circulating tumor cells during follow-up of patients with operable breast cancer: prognostic relevance for late relapse Saloustros, Emmanouil
2011
3 artikel
46 DAX-1 expression in human breast cancer: comparison with estrogen receptors ER-α, ER-β and androgen receptor status Conde, Isabel
2004
3 p. R140-R148
artikel
47 Dendritic cells are defective in breast cancer patients: a potential role for polyamine in this immunodeficiency Gervais, Alban
2005
3 p. R326-R335
artikel
48 Detection of hepatocyte growth factor/scatter factor receptor (c-Met) in axillary drainage after operations for breast cancer using reverse transcriptase–polymerase chain reaction Greenberg, Ron
2003
3 p. R71-R76
artikel
49 Determining sensitivity and specificity of HER2 testing in breast cancer using a tissue micro-array approach Dekker, Tim JA
2012
3 artikel
50 Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development Rivas, Martin A
2012
3 artikel
51 Dual-energy contrast-enhanced digital mammography: initial clinical results of a multireader, multicase study Dromain, Clarisse
2012
3 artikel
52 Dynamic changes in gene expression in vivo predict prognosis of tamoxifen-treated patients with breast cancer Taylor, Karen J
2010
3 artikel
53 Effects of common germline genetic variation in cell cycle control genes on breast cancer survival: results from a population-based cohort Azzato, Elizabeth M
2008
3 artikel
54 Elevated expression of syntenin in breast cancer is correlated with lymph node metastasis and poor patient survival Yang, Yu
2013
3 artikel
55 Elevated insulin-like growth factor 1 receptor signaling induces antiestrogen resistance through the MAPK/ERK and PI3K/Akt signaling routes Zhang, Yinghui
2011
3 artikel
56 Elevated mammaglobin (h-MAM) expression in breast cancer is associated with clinical and biological features defining a less aggressive tumour phenotype Núñez-Villar, MJ
2003
3 p. R65-R70
artikel
57 Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort study Allin, Kristine H
2011
3 artikel
58 Endogenous sex steroids in premenopausal women and risk of breast cancer: the ORDET cohort Schernhammer, Eva S
2013
3 artikel
59 Endometrial cancer survival after breast cancer in relation to tamoxifen treatment: Pooled results from three countries Jones, Michael E
2012
3 artikel
60 Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors Kwan, Marilyn L
2009
3 artikel
61 Epidermal growth factor suppresses induction by progestin of the adhesion protein desmoplakin in T47D breast cancer cells Pang, Haiyan
2004
3 p. R239-R245
artikel
62 Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients Kallergi, Galatea
2011
3 artikel
63 Estrogen and progesterone induce persistent increases in p53-dependent apoptosis and suppress mammary tumors in BALB/c-Trp53+/- mice Dunphy, Karen A
2008
3 artikel
64 Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors Sunami, Eiji
2008
3 artikel
65 Estrogen receptor-α polymorphism in a Taiwanese clinical breast cancer population: a case–control study Hsiao, Wei-Chiang
2004
3 p. R180-R186
artikel
66 Evaluation of Ki-67 proliferation and apoptotic index before, during and after neoadjuvant chemotherapy for primary breast cancer Burcombe, Russell
2006
3 artikel
67 Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours Albergaria, André
2009
3 artikel
68 Expression of LRP and MDR1 in locally advanced breast cancer predicts axillary node invasion at the time of rescue mastectomy after induction chemotherapy Schneider, José
2001
3 p. 183-191
artikel
69 Expression of the epidermal growth factor receptor (EGFR) and the phosphorylated EGFR in invasive breast carcinomas Magkou, Christina
2008
3 artikel
70 Extended adjuvant hormonal therapy with exemestane has no detrimental effect on the lipid profile of postmenopausal breast cancer patients: final results of the ATENA lipid substudy Markopoulos, Christos
2009
3 artikel
71 Frequent loss of endothelin-3 (EDN3) expression due to epigenetic inactivation in human breast cancer Wiesmann, Frank
2009
3 artikel
72 Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer Alix-Panabières, Catherine
2009
3 artikel
73 Geminin overexpression prevents the completion of topoisomerase IIα chromosome decatenation, leading to aneuploidy in human mammary epithelial cells Gardner, Lauren
2011
3 artikel
74 Gene expression in murine mammary epithelial stem cell-like cells shows similarities to human breast cancer gene expression Williams, Cecilia
2009
3 artikel
75 Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer Sotiriou, Christos
2002
3 artikel
76 Genetic determinants of mammographic density Haiman, Christopher A
2002
3 artikel
77 Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics Jönsson, Göran
2010
3 artikel
78 Genotype of metabolic enzymes and the benefit of tamoxifen in postmenopausal breast cancer patients Wegman, Pia
2005
3 p. R284-R290
artikel
79 HER2 gene status in primary breast cancers and matched distant metastases Tapia, Coya
2007
3 artikel
80 HER-2 positive breast cancer: decreasing proportion but stable incidence in Finnish population from 1982 to 2005 Köninki, Katri
2009
3 artikel
81 High mammographic density in women of Ashkenazi Jewish descent Caswell, Jennifer L
2013
3 artikel
82 High-resolution genomic and expression analyses of copy number alterations in HER2-amplified breast cancer Staaf, Johan
2010
3 artikel
83 Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter? Gruber, Günther
2004
3 p. R191-R198
artikel
84 Immunohistochemical characterization of subtypes of male breast carcinoma Ge, Yimin
2009
3 artikel
85 Impact of established prognostic factors and molecular subtype in very young breast cancer patients: pooled analysis of four EORTC randomized controlled trials van der Hage, Jos A
2011
3 artikel
86 Impact of UGT2B7 His268Tyr polymorphism on the outcome of adjuvant epirubicin treatment in breast cancer Parmar, Sumit
2011
3 artikel
87 Implications of constructed biologic subtype and its relationship to locoregional recurrence following mastectomy Dominici, Laura S
2012
3 artikel
88 Incorporating tumour pathology information into breast cancer risk prediction algorithms Mavaddat, Nasim
2010
3 artikel
89 Induction by transforming growth factor-β1 of epithelial to mesenchymal transition is a rare event in vitro Brown, Kimberly A
2004
3 p. R215-R231
artikel
90 Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome Arpino, Grazia
2004
3 p. R149-R156
artikel
91 Inhibition of phosphatidylcholine-specific phospholipase C downregulates HER2 overexpression on plasma membrane of breast cancer cells Paris, Luisa
2010
3 artikel
92 Intact and total insulin-like growth factor-binding protein-3 (IGFBP-3) levels in relation to breast cancer risk factors: a cross-sectional study Diorio, Caroline
2008
3 artikel
93 Invasive breast cancer induces laminin-332 upregulation and integrin β4 neoexpression in myofibroblasts to confer an anoikis-resistant phenotype during tissue remodeling Kim, Baek Gil
2012
3 artikel
94 Is breast cancer prognosis inherited? Hartman, Mikael
2007
3 artikel
95 Jab1 is a target of EGFR signaling in ERα-negative breast cancer Wang, Jiaxu
2008
3 artikel
96 JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer Lee, Yi Fang
2012
3 artikel
97 Keratin 6 is not essential for mammary gland development Grimm, Sandra L
2006
3 artikel
98 Leptin-signaling inhibition results in efficient anti-tumor activity in estrogen receptor positive or negative breast cancer Rene Gonzalez, Ruben
2009
3 artikel
99 Liver × receptor ligands disrupt breast cancer cell proliferation through an E2F-mediated mechanism Nguyen-Vu, Trang
2013
3 artikel
100 Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy Caudle, Abigail S
2012
3 artikel
101 Loss of plakoglobin promotes decreased cell-cell contact, increased invasion, and breast cancer cell dissemination in vivo Holen, Ingunn
2012
3 artikel
102 Low E2F1 transcript levels are a strong determinant of favorable breast cancer outcome Vuaroqueaux, Vincent
2007
3 artikel
103 Low frequency of E-cadherin alterations in familial breast cancer Salahshor, Sima
2001
3 p. 199-207
artikel
104 Mammary carcinoma behavior is programmed in the precancer stem cell Damonte, Patrizia
2008
3 artikel
105 Mammographic density and breast cancer: a comparison of related and unrelated controls in the Breast Cancer Family Registry Linton, Linda
2013
3 artikel
106 Mammographic density and survival in interval breast cancers Eriksson, Louise
2013
3 artikel
107 Mammographic density does not correlate with Ki-67 expression or cytomorphology in benign breast cells obtained by random periareolar fine needle aspiration from women at high risk for breast cancer Khan, Qamar J
2007
3 artikel
108 Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells Grimshaw, Matthew J
2008
3 artikel
109 MicroRNA-34a and microRNA-21 play roles in the chemopreventive effects of 3,6-dihydroxyflavone on 1-methyl-1-nitrosourea-induced breast carcinogenesis Hui, Chang
2012
3 artikel
110 MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer Lowery, Aoife J
2009
3 artikel
111 Modulation of N-methyl-N-nitrosourea induced mammary tumors in Sprague–Dawley rats by combination of lysine, proline, arginine, ascorbic acid and green tea extract Roomi, M Waheed
2005
3 p. R291-R295
artikel
112 Molecular analysis of metastasis in a polyomavirus middle T mouse model: the role of osteopontin Jessen, Katayoun Alavi
2004
3 p. R157-R169
artikel
113 Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15 Lehmann-Che, Jacqueline
2013
3 artikel
114 Molecular response to aromatase inhibitor treatment in primary breast cancer Mackay, Alan
2007
3 artikel
115 Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns Holm, Karolina
2010
3 artikel
116 Muscarinic receptors participation in angiogenic response induced by macrophages from mammary adenocarcinoma-bearing mice de la Torre, Eulalia
2005
3 p. R345-R352
artikel
117 Mutation analysis of the CHK2 gene in breast carcinoma and other cancers Ingvarsson, Sigurdur
2002
3 artikel
118 Nongenomic oestrogen signalling in oestrogen receptor negative breast cancer cells: a role for the angiotensin II receptor AT1 Lim, Kheng Tian
2006
3 artikel
119 NOTCH-1 and NOTCH-4 are novel gene targets of PEA3 in breast cancer: novel therapeutic implications Clementz, Anthony G
2011
3 artikel
120 Novel design principles enable specific targeting of imaging and therapeutic agents to necrotic domains in breast tumors Goldshaid, Liat
2010
3 artikel
121 Optimal tumor sampling for immunostaining of biomarkers in breast carcinoma Tolles, Juliana
2011
3 artikel
122 Outcome and Human Epithelial Growth Factor Receptor (HER) 1-4 status in invasive breast carcinomas with proliferation indices evaluated using bromodeoxyuridine (BrdU) labelling Tovey, Sian M
2004
3 artikel
123 Overdiagnosis in breast cancer screening: the importance of length of observation period and lead time Duffy, Stephen W
2013
3 artikel
124 Paracrine interactions between primary human macrophages and human fibroblasts enhance murine mammary gland humanization in vivo Fleming, Jodie M
2012
3 artikel
125 Phosphorylated and sumoylation-deficient progesterone receptors drive proliferative gene signatures during breast cancer progression Knutson, Todd P
2012
3 artikel
126 PI-3 kinase activity is necessary for ERK1/2-induced disruption of mammary epithelial architecture Pearson, Gray W
2009
3 artikel
127 Pilot phase III immunotherapy study in early-stage breast cancer patients using oxidized mannan-MUC1 [ISRCTN71711835] Apostolopoulos, Vasso
2006
3 artikel
128 Plasma 25-hydroxyvitamin D and risk of breast cancer in the Nurses' Health Study II Eliassen, A Heather
2011
3 artikel
129 PMC42, a breast progenitor cancer cell line, has normal-like mRNA and microRNA transcriptomes Git, Anna
2008
3 artikel
130 Polyclonal HER2-specific antibodies induced by vaccination mediate receptor internalization and degradation in tumor cells Ren, Xiu-Rong
2012
3 artikel
131 Polymorphisms in genes involved in estrogen and progesterone metabolism and mammographic density changes in women randomized to postmenopausal hormone therapy: results from a pilot study Lord, Sarah J
2005
3 p. R336-R344
artikel
132 Potential for the embryonic morphogen Nodal as a prognostic and predictive biomarker in breast cancer Strizzi, Luigi
2012
3 artikel
133 Preclinical and clinical studies of estrogen deprivation support the PDGF/Abl pathway as a novel therapeutic target for overcoming endocrine resistance in breast cancer Weigel, Marion T
2012
3 artikel
134 Pregnancy-related factors and the risk of breast carcinoma in situ and invasive breast cancer among postmenopausal women in the California Teachers Study cohort Ma, Huiyan
2010
3 artikel
135 Progesterone metabolites regulate induction, growth, and suppression of estrogen- and progesterone receptor-negative human breast cell tumors Wiebe, John P
2013
3 artikel
136 Progesterone reverses the mesenchymal phenotypes of basal phenotype breast cancer cells via a membrane progesterone receptor mediated pathway Zuo, Lian
2010
3 artikel
137 Prognostic and predictive value of TP53 mutations in node-positive breast cancer patients treated with anthracycline- or anthracycline/taxane-based adjuvant therapy: results from the BIG 02-98 phase III trial Fernández-Cuesta, Lynnette
2012
3 artikel
138 Prospectively measured triiodothyronine levels are positively associated with breast cancer risk in postmenopausal women Tosovic, Ada
2010
3 artikel
139 Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer Creighton, Chad J
2010
3 artikel
140 QLT0267, a small molecule inhibitor targeting integrin-linked kinase (ILK), and docetaxel can combine to produce synergistic interactions linked to enhanced cytotoxicity, reductions in P-AKT levels, altered F-actin architecture and improved treatment outcomes in an orthotopic breast cancer model Kalra, Jessica
2009
3 artikel
141 Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women Jemal, Ahmedin
2007
3 artikel
142 Red clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial [ISRCTN42940165] Atkinson, Charlotte
2004
3 p. R170-R179
artikel
143 Relationship between intratumoral expression of genes coding for xenobiotic-metabolizing enzymes and benefit from adjuvant tamoxifen in estrogen receptor alpha-positive postmenopausal breast carcinoma Bièche, Ivan
2004
3 p. R252-R263
artikel
144 Reversal of endocrine resistance in breast cancer: interrelationships among 14-3-3ζ, FOXM1, and a gene signature associated with mitosis Bergamaschi, Anna
2011
3 artikel
145 Risk factors for breast cancer characterized by the estrogen receptor alpha A908G (K303R) mutation Conway, Kathleen
2007
3 artikel
146 RNA interference (RNAi) screening approach identifies agents that enhance paclitaxel activity in breast cancer cells Bauer, Joshua A
2010
3 artikel
147 Role of thioredoxin reductase 1 and thioredoxin interacting protein in prognosis of breast cancer Cadenas, Cristina
2010
3 artikel
148 Roscovitine confers tumor suppressive effect on therapy-resistant breast tumor cells Nair, Binoj C
2011
3 artikel
149 γ-Secretase inhibition promotes cell death, Noxa upregulation, and sensitization to BH3 mimetic ABT-737 in human breast cancer cells Séveno, Céline
2012
3 artikel
150 Senescence evasion by MCF-7 human breast tumor-initiating cells Karimi-Busheri, Feridoun
2010
3 artikel
151 Serum biomarker profiles and response to neoadjuvant chemotherapy for locally advanced breast cancer Nolen, Brian M
2008
3 artikel
152 Serum microRNA expression as an early marker for breast cancer risk in prospectively collected samples from the Sister Study cohort Godfrey, Ashley C
2013
3 artikel
153 Sex steroids, growth factors and mammographic density: a cross-sectional study of UK postmenopausal Caucasian and Afro-Caribbean women McCormack, Valerie A
2009
3 artikel
154 Stat3 and CCAAT/enhancer binding protein beta (C/EBP-beta) regulate Jab1/CSN5 expression in mammary carcinoma cells Shackleford, Terry J
2011
3 artikel
155 Stat3 is tyrosine-phosphorylated through the interleukin-6/glycoprotein 130/Janus kinase pathway in breast cancer Berishaj, Marjan
2007
3 artikel
156 Study design: Evaluating gene–environment interactions in the etiology of breast cancer – the WECARE study Bernstein, Jonine L
2004
3 p. R199-R214
artikel
157 Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3 Kodera, Yasuo
2011
3 artikel
158 Surface-enhanced laser desorption/ionization time-of-flight proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expression Brozkova, Kristyna
2008
3 artikel
159 Synergy between trastuzumab and pertuzumab for human epidermal growth factor 2 (Her2) from colocalization: an in silico based mechanism Fuentes, Gloria
2011
3 artikel
160 Targeting inhibitor of apoptosis proteins in combination with ErbB antagonists in breast cancer Foster, Fiona M
2009
3 artikel
161 Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat Tate, Chandra R
2012
3 artikel
162 Telomerase expression and telomere length in breast cancer and their associations with adjuvant treatment and disease outcome Lu, Lingeng
2011
3 artikel
163 The AIB1 glutamine repeat polymorphism is not associated with risk of breast cancer before age 40 years in Australian women Montgomery, Karen G
2005
3 p. R353-R356
artikel
164 The association of mammographic density with ductal carcinoma in situ of the breast: the Multiethnic Cohort Gill, Jasmeet K
2006
3 artikel
165 The CD44+/CD24- phenotype is enriched in basal-like breast tumors Honeth, Gabriella
2008
3 artikel
166 The effect of the stromal component of breast tumours on prediction of clinical outcome using gene expression microarray analysis Cleator, Susan J
2006
3 artikel
167 The estrogen receptor influences microtubule-associated protein tau (MAPT) expression and the selective estrogen receptor inhibitor fulvestrant downregulates MAPT and increases the sensitivity to taxane in breast cancer cells Ikeda, Hirokuni
2010
3 artikel
168 The expression and significance of insulin-like growth factor-1 receptor and its pathway on breast cancer stem/progenitors Chang, Wen-Wei
2013
3 artikel
169 The influence of MMP-14, TIMP-2 and MMP-2 expression on breast cancer prognosis Têtu, Bernard
2006
3 artikel
170 The membrane cytoskeletal crosslinker ezrin is required for metastasis of breast carcinoma cells Elliott, Bruce E
2005
3 p. R365-R373
artikel
171 The prognostic significance of tumour cell detection in the peripheral blood versus the bone marrow in 733 early-stage breast cancer patients Molloy, Timothy J
2011
3 artikel
172 The role of chemotherapeutic drugs in the evaluation of breast tumour response to chemotherapy using serial FDG-PET Schneider-Kolsky, Michal E
2010
3 artikel
173 The role of YY1 in reduced HP1α gene expression in invasive human breast cancer cells Lieberthal, Jason G
2009
3 artikel
174 TIMP-2 mediates the anti-invasive effects of the nitric oxide-releasing prodrug JS-K in breast cancer cells Simeone, Ann-Marie
2008
3 artikel
175 TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer Langerød, Anita
2007
3 artikel
176 Variation in the RAD51 gene and familial breast cancer Lose, Felicity
2006
3 artikel
177 WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth Matsuda, Yutaka
2009
3 artikel
                             177 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland